Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy

INTRODUCTION: Tripterygium glycosides (TGs) have been widely used in China to treat diabetic nephropathy (DN); however, proof of their use is scarce. The present study aimed to evaluate the effectiveness and safety of adding TGs to angiotensin-converting enzyme (ACE) inhibitors or angiotensin recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jin-Ying, Yang, Yue, Zhang, Zheng, Jiang, Shi-Min, Yu, Tian-Yu, Li, Wen-Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2020
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096323/
https://www.ncbi.nlm.nih.gov/pubmed/32226931
http://dx.doi.org/10.1016/j.cdtm.2019.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096323/
https://www.ncbi.nlm.nih.gov/pubmed/32226931
http://dx.doi.org/10.1016/j.cdtm.2019.12.008

Ejemplares similares